The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Abstract
OBJECTIVE: Cryptococcal meningitis is one of the most important HIV-related opportunistic infections, especially in the developing world. In order to help develop global strategies and priorities for prevention and treatment, it is important to estimate the burden of cryptococcal meningitis. DESIGN: Global burden of disease estimation using published studies. METHODS: We used the median incidence rate of available studies in a geographic region to estimate the region-specific cryptococcal meningitis incidence; this was multiplied by the 2007 United Nations Programme on HIV/AIDS HIV population estimate for each region to estimate cryptococcal meningitis cases. To estimate deaths, we assumed a 9% 3-month case-fatality rate among high-income regions, a 55% rate among low-income and middle-income regions, and a 70% rate in sub-Saharan Africa, based on studies published in these areas and expert opinion. RESULTS: Published incidence ranged from 0.04 to 12% per year among persons with HIV. Sub-Saharan Africa had the highest yearly burden estimate (median incidence 3.2%, 720 000 cases; range, 144 000-1.3 million). Median incidence was lowest in Western and Central Europe and Oceania (</=0.1% each). Globally, approximately 957 900 cases (range, 371 700-1 544 000) of cryptococcal meningitis occur each year, resulting in 624 700 deaths (range, 125 000-1 124 900) by 3 months after infection. CONCLUSION: This study, the first attempt to estimate the global burden of cryptococcal meningitis, finds the number of cases and deaths to be very high, with most occurring in sub-Saharan Africa. Further work is needed to better define the scope of the problem and track the epidemiology of this infection, in order to prioritize prevention, diagnosis, and treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 820
Kaplan, J. E., Hanson, D., Dworkin, M. S., Frederick, T., Bertolli, J., Lindegren, M. L., Holmberg, S., & Jones, J. L. (2000) · Clinical Infectious Diseases · doi:10.1086/313843 · Cited by 705
HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998
Sacktor, N., Lyles, R. H., Skolasky, R., Kleeberger, C., Selnes, O. A., Miller, E. N., Becker, J. T., Cohen, B., McArthur, J. C., & Study*, T. M. A. C. (2001) · Neurology · doi:10.1212/wnl.56.2.257 · Cited by 591
Mirza, S. A., Phelan, M., Rimland, D., Graviss, E., Hamill, R., Brandt, M. E., Gardner, T., Sattah, M., Ponce de Leon, G., Baughman, W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/368091 · Cited by 459
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
French, N., Gray, K., Watera, C., Nakiyingi, J., Lugada, E., Moore, M., Lalloo, D., Whitworth, J. A. G., & Gilks, C. F. (2002) · AIDS · doi:10.1097/00002030-200205030-00009 · Cited by 417
Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321102 · Cited by 318
Hajjeh, R. A., Conn, L. A., Stephens, D. S., Baughman, W., Hamill, R., Graviss, E., Pappas, P. G., Thomas, C., Reingold, A., Rothrock, G., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314606 · Cited by 275
Self-citationComparison of commercial kits for detection of cryptococcal antigen
Tanner, D. C., Weinstein, M. P., Fedorciw, B., Joho, K. L., Thorpe, J. J., & Reller, L. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.7.1680-1684.1994 · Cited by 236
Natural History of Human Immunodeficiency Virus Disease in Southern India
Kumarasamy, N., Solomon, S., Flanigan, T. P., Hemalatha, R., Thyagarajan, S. P., & Mayer, K. H. (2003) · Clinical Infectious Diseases · doi:10.1086/344756 · Cited by 227
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
Lortholary, O., Poizat, G., Zeller, V., Neuville, S., Boibieux, A., Alvarez, M., Dellamonica, P., Botterel, F., Dromer, F., & Chêne, G. (2006) · AIDS · doi:10.1097/01.aids.0000252060.80704.68 · Cited by 198
Cited by
Items 101–145 of 145
Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
Lu, R., Hollingsworth, C., Qiu, J., Wang, A., Hughes, E., Xin, X., Konrath, K. M., Elsegeiny, W., Park, Y.-D., Atakulu, L., et al. (2019) · mBio · doi:10.1128/mbio.00724-19 · Cited by 67
Lockhart, S. R., Fothergill, A. W., Iqbal, N., Bolden, C. B., Grossman, N. T., Garvey, E. P., Brand, S. R., Hoekstra, W. J., Schotzinger, R. J., Ottinger, E., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02770-15 · Cited by 67
End-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis
Spec, A., Raval, K., & Powderly, W. G. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv197 · Cited by 65
“Worldwide, it is estimated that there are 1 million cases and 625 000 deaths annually due to cryptococcal meningitis in HIV-infected individuals alone [3].”
BackgroundLong, M., Huang, S.-H., Wu, C.-H., Shackleford, G. M., & Jong, A. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-19 · Cited by 64
Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63
Cordeiro, R. D. A., Evangelista, A. J. D. J., Serpa, R., Marques, F. J. D. F., Melo, C. V. S. D., Oliveira, J. S. D., Franco, J. D. S., Alencar, L. P. D., Bandeira, T. D. J. P. G., Brilhante, R. S. N., et al. (2016) · Microbiology · doi:10.1099/mic.0.000222 · Cited by 63
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55
Evans, R. J., Li, Z., Hughes, W. S., Djordjevic, J. T., Nielsen, K., & May, R. C. (2015) · Infection and Immunity · doi:10.1128/iai.03104-14 · Cited by 53
Antimicrobial and antiprotozoal activities of twenty-four Nigerian medicinal plant extracts
Ogbole, O. O., Segun, P. A., & Fasinu, P. S. (2018) · South African Journal of Botany · doi:10.1016/j.sajb.2018.05.028 · Cited by 52
Discovery of a Novel Antifungal Agent in the Pathogen Box
Mayer, F. L., & Kronstad, J. W. (2017) · mSphere · doi:10.1128/msphere.00120-17 · Cited by 49
Parkes‐Ratanshi, R., Achan, B., Kwizera, R., Kambugu, A., Meya, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12387 · Cited by 49
O'Meara, T. R., & Cowen, L. E. (2014) · Cellular Microbiology · doi:10.1111/cmi.12266 · Cited by 48
Kim, J.-C., Crary, B., Chang, Y. C., Kwon-Chung, K. J., & Kim, K. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.389676 · Cited by 47
Meya, D. B., Kiragga, A. N., Nalintya, E., Morawski, B. M., Rajasingham, R., Park, B. J., Mubiru, A., Kaplan, J. E., Manabe, Y. C., Boulware, D. R., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001894 · Cited by 47
Self-citationOld Cryptococcus neoformans Cells Contribute to Virulence in Chronic Cryptococcosis
Bouklas, T., Pechuan, X., Goldman, D. L., Edelman, B., Bergman, A., & Fries, B. C. (2013) · mBio · doi:10.1128/mbio.00455-13 · Cited by 46
Eugenin, E. A., Greco, J. M., Frases, S., Nosanchuk, J. D., & Martinez, L. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit117 · Cited by 45
Emerging themes in cryptococcal capsule synthesis
Kumar, P., Yang, M., Haynes, B. C., Skowyra, M. L., & Doering, T. L. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.006 · Cited by 44
Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells
Teixeira, P. A. C., Penha, L. L., Mendonça-Previato, L., & Previato, J. O. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00106 · Cited by 44
Burden of serious fungal infections in Tanzania
Faini, D., Maokola, W., Furrer, H., Hatz, C., Battegay, M., Tanner, M., Denning, D. W., & Letang, E. (2015) · Mycoses · doi:10.1111/myc.12390 · Cited by 42
Methamphetamine Enhances Cryptococcus neoformans Pulmonary Infection and Dissemination to the Brain
Patel, D., Desai, G. M., Frases, S., Cordero, R. J. B., DeLeon-Rodriguez, C. M., Eugenin, E. A., Nosanchuk, J. D., & Martinez, L. R. (2013) · mBio · doi:10.1128/mbio.00400-13 · Cited by 43
Zhang, M., Sun, D., Liu, G., Wu, H., Zhou, H., & Shi, M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ab0715-281r · Cited by 42
Pianalto, K. M., Billmyre, R. B., Telzrow, C. L., & Alspaugh, J. A. (2019) · Genetics · doi:10.1534/genetics.119.302290 · Cited by 41
Robbins, N., Spitzer, M., Wang, W., Waglechner, N., Patel, D. J., O’Brien, J. S., Ejim, L., Ejim, O., Tyers, M., & Wright, G. D. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.08.015 · Cited by 41
Marcyk, P. T., LeBlanc, E. V., Kuntz, D. A., Xue, A., Ortiz, F., Trilles, R., Bengtson, S., Kenney, T. M. G., Huang, D. S., Robbins, N., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01777 · Cited by 40
Regulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi
Pijuan, J., Moreno, D. F., Yahya, G., Moisa, M., Ul Haq, I., Krukiewicz, K., Mosbah, R., Metwally, K., & Cavalu, S. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14346 · Cited by 37
“Cryptococcus neoformans is a human fungal pathogen that can cause meningoencephalitis in immunocompromised individuals, especially on those affected by HIV/ AIDS in developing countries (Park et al., 2009) with a very high mortality rate.”
BackgroundEstimated burden of fungal infections in Kenya
Guto, J. A., Bii, C. C., & Denning, D. W. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7614 · Cited by 36
Villanueva-Lozano, H., Treviño-Rangel, R. D. J., González, G. M., Hernández-Rodríguez, P. A., Camacho-Ortiz, A., Castillo-Reyna, L., Galindo-Alvarado, S. G., & Martínez-Reséndez, M. F. (2018) · Infection · doi:10.1007/s15010-017-1059-3 · Cited by 35
Connecting iron regulation and mitochondrial function in Cryptococcus neoformans
Horianopoulos, L. C., & Kronstad, J. W. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.04.002 · Cited by 32
Fungal Infection in the Brain: What We Learned from Intravital Imaging
Shi, M., & Mody, C. H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00292 · Cited by 33
A High-Throughput Screening Assay for Fungicidal Compounds against Cryptococcus neoformans
Rabjohns, J. L. A., Park, Y.-D., Dehdashti, J., Sun, W., Henderson, C., Zelazny, A., Metallo, S. J., Zheng, W., & Williamson, P. R. (2014) · SLAS Discovery · doi:10.1177/1087057113496847 · Cited by 33
“Cryptococcus is an opportunistic pathogen that mainly affects immunocompetent and immunocompromised individuals worldwide, killing approximately 600,000 people per year.(1) In the United States, cryptococcal infection continues to be a problem, with an estimated $54 million in direct hospitalization costs per year.”
BackgroundSabiiti, W., & May, R. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035455 · Cited by 31
Mohammad, H., Elghazawy, N. H., Eldesouky, H. E., Hegazy, Y. A., Younis, W., Avrimova, L., Hazbun, T., Arafa, R. K., & Seleem, M. N. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00215 · Cited by 29
Silva, L. I. D., Karuppusamy, A., Miyajima, F., Violante, I. M. P., Bieski, I. G. C., Balogun, S. O., & Martins, D. T. D. O. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i5.17086 · Cited by 29
Sun, D., Zhang, M., Liu, G., Wu, H., Li, C., Zhou, H., Zhang, X., & Shi, M. (2016) · European Journal of Immunology · doi:10.1002/eji.201546239 · Cited by 28
Ngan, N. T. T., Mai, N. T. H., Tung, N. L. N., Lan, N. P. H., Tai, L. T. H., Phu, N. H., Chau, N. V. V., Binh, T. Q., Hung, L. Q., Beardsley, J., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15010.1 · Cited by 28
Wiederhold, N. P., Najvar, L. K., Garvey, E. P., Brand, S. R., Xu, X., Ottinger, E. A., Alimardanov, A., Cradock, J., Behnke, M., Hoekstra, W. J., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01071-18 · Cited by 27
Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs
Nielsen, K., Vedula, P., Smith, K. D., Meya, D. B., Garvey, E. P., Hoekstra, W. J., Schotzinger, R. J., & Boulware, D. R. (2016) · Medical Mycology · doi:10.1093/mmy/myw089 · Cited by 24
Hartland, K., Pu, J., Palmer, M., Dandapani, S., Moquist, P. N., Munoz, B., DiDone, L., Schreiber, S. L., & Krysan, D. J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00111 · Cited by 24
Iron acquisition in the human fungal pathogen Cryptococcus neoformans
Jung, W. H., & Do, E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.07.008 · Cited by 18
Gerlach, E. S., Altamirano, S., Yoder, J. M., Luggya, T. S., Akampurira, A., Meya, D. B., Boulware, D. R., Rhein, J., & Nielsen, K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.695240 · Cited by 17
García-Barbazán, I., Torres-Cano, A., García-Rodas, R., Sachse, M., Luque, D., Megías, D., & Zaragoza, O. (2024) · mBio · doi:10.1128/mbio.02549-23 · Cited by 14
Liu, J., Liu, J., Su, X., Yang, L., Wang, Y., Wang, A., Xu, X., Li, M., Jiang, Y., & Peng, F. (2022) · BMC Neurology · doi:10.1186/s12883-022-02803-1 · Cited by 14
“There are two possible reasons for these differences: (1) the sources of the enrolled cases were not identical (one was from the Third A liated Hospital of Sun Yat Sen University, and the other was from the Third A liated Hospital of Sun Yat Sen University and Jiangxi Chest Hospital); (2) the time spans of patient inc…”
BackgroundMethodResultInfluentialThiazole derivatives act on virulence factors of Cryptococcus spp.
de Sá, N. P., de Barros, P. P., Junqueira, J. C., Vaz, J. A., de Oliveira, R. B., Rosa, C. A., Santos, D. A., & Johann, S. (2019) · Medical Mycology · doi:10.1093/mmy/myx158 · Cited by 13
Bhatt, M., Porterfield, J. Z., Ribes, J. A., Arora, V., & Myint, T. (2021) · Mycoses · doi:10.1111/myc.13323 · Cited by 13
Stie, J., & Fox, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049402 · Cited by 12
Metadata
- Authors
- Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., & Chiller, T. M.
- Venue
- AIDS
- Published
- 2009-02-20
- Volume
- 23
- Issue
- 4
- Pages
- 525-530
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2079513681
- Cited by
- 2,014
- References
- 33
- FWCI
- 71.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.